As we thought, but not as much revenue as we thought, see what the market thinks...
TCG
Joondalup Health Campus enters an agreement for full commercial rollout of HeraCARE:
● Joondalup Health Campus (JHC) has entered into a full-scale long-term commercial agreement with medical data and technology company HeraMED (ASX:HMD) to adopt the complete HeraCARE solution as the primary standard of care offered for their audience of expecting mothers
● Commercial terms reached under the paid pilot agreement, including the SaaS fees, will extend for 12 months, with both parties exploring extension of the contract for a further three years
● The contract value for the first 12 months is expected to be approximately A$220,000
● HMD will progressively deliver HeraCARE SaaS licences (including the HeraBEAT smart foetal monitors) to support JHC’s services expansion
● This is the first major Healthcare group to adopt the comprehensive HeraCARE virtual and remote monitoring solution as part of their innovative care model for pregnant mothers
● This agreement validates HeraMED’s commercialisation strategy undertaking clinical trials leading to paid pilots and then ultimately full commercial deployment within a leading hospital group
● JHC (part of Ramsay Health Care) is one of Western Australia’s largest hospitals, a leading medical institution, and a maternity care service provider to an average of 3,000 expectant mothers annually
HMD Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
